• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

SII manufacturing first batch of Covovax COVID-19 vaccine, says Poonawalla

By
|
Google Oneindia News

Pune, Jun 25:The first batch of Covovax, a COVID-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India’s Pune facility, SII CEO Adar Poonawalla said on Friday.

SII manufacturing first batch of Covovax COVID-19 vaccine, says Poonawalla

"Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune. The vaccine has great potential to protect our future generations below the age of 18. Trials are ongoing. Well done team @seruminstindia," Poonawalla said in a tweet.

Delta plus variant: Maharashtra imposes stricter norms, Level 3 curbs to continue to contain COVID-19 spreadDelta plus variant: Maharashtra imposes stricter norms, Level 3 curbs to continue to contain COVID-19 spread

In March this year, he had said that the clinical trials of Covovax vaccine have begun in India and the company hopes to launch it by September this year.

In August 2020, American vaccine company Novavax Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.

In January this year, the Serum Institute had rolled out Covishield vaccine in the country. It had entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X